BRIACELL THERAP (BCTX) vs NanoViricides, Inc. (NNVC)
BRIACELL THERAP and NanoViricides, Inc. are both Biotechnology companies. BRIACELL THERAP and NanoViricides, Inc. are of similar size ($38.0M and $37.2M). NanoViricides, Inc. has negative trailing earnings, so its P/E is not meaningful; BRIACELL THERAP trades at 1.9×. Across the 9 metrics below, NanoViricides, Inc. leads on 6 and BRIACELL THERAP on 3.
Valuation
Profitability
| Metric | BCTX | NNVC | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (173.55%) | (89.97%) | (57.72%) |
| Return on assets | (139.20%) | (79.91%) | (49.22%) |
| Return on invested capital | (3,311.00%) | (86.02%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack